National Academies Press: OpenBook

Building Resilience into the Nation's Medical Product Supply Chains (2022)

Chapter: Appendix F: Disclosure of Unavoidable Conflict of Interest

« Previous: Appendix E: Committee and Staff Biosketches
Suggested Citation:"Appendix F: Disclosure of Unavoidable Conflict of Interest." National Academies of Sciences, Engineering, and Medicine. 2022. Building Resilience into the Nation's Medical Product Supply Chains. Washington, DC: The National Academies Press. doi: 10.17226/26420.
×

Appendix F

Disclosure of Unavoidable Conflict of Interest

The conflict of interest policy of the National Academies of Sciences, Engineering, and Medicine (http://www.nationalacademies.org/coi) prohibits the appointment of an individual to a committee authoring a Consensus Study Report if the individual has a conflict of interest that is relevant to the task to be performed. An exception to this prohibition is permitted if the National Academies determines that the conflict is unavoidable and the conflict is publicly disclosed. A determination of a conflict of interest for an individual is not an assessment of that individual’s actual behavior or character or ability to act objectively despite the conflicting interest.

Robert M. Califf has a conflict of interest in relation to his service on the Committee on Security of America’s Medical Product Supply Chain because he is employed by Verily Life Sciences and has current relationships with Google Health and Cytokinetics.

The National Academies has concluded that for this committee to accomplish the tasks for which it was established, its membership must include at least one person who has substantial relevant experience in FDA regulatory policy, drug and device development, drug and device manufacturing, and drug shortages. As described in his biographical summary, Dr. Califf has extensive current experience as Head of Clinical Policy and Strategy for Verily Life Sciences and Google Health in FDA regulatory policy, drug and device development and manufacturing. As Commissioner of the U.S. Food and Drug Administration (FDA), and as Deputy Commissioner for Medical Products and Tobacco, Dr. Califf gained valuable expertise and perspective on the entirety of the health care ecosystem, including companies, hospitals, and health systems. Additionally, Dr. Califf has led clinical

Suggested Citation:"Appendix F: Disclosure of Unavoidable Conflict of Interest." National Academies of Sciences, Engineering, and Medicine. 2022. Building Resilience into the Nation's Medical Product Supply Chains. Washington, DC: The National Academies Press. doi: 10.17226/26420.
×

research studies and clinical trials and previously served as vice chancellor of clinical and translational research and the director of the Duke Translational Medicine Institute.

The National Academies has determined that the experience and expertise of Dr. Califf is needed for the committee to accomplish the task for which it has been established. The National Academies could not find another available individual with the equivalent experience and expertise who does not have a conflict of interest. Therefore, the National Academies has concluded that the conflict is unavoidable.

The National Academies believes that Dr. Califf can serve effectively as a member of the committee, and the committee can produce an objective report, taking into account the composition of the committee, the work to be performed, and the procedures to be followed in completing the study.

Suggested Citation:"Appendix F: Disclosure of Unavoidable Conflict of Interest." National Academies of Sciences, Engineering, and Medicine. 2022. Building Resilience into the Nation's Medical Product Supply Chains. Washington, DC: The National Academies Press. doi: 10.17226/26420.
×
Page 335
Suggested Citation:"Appendix F: Disclosure of Unavoidable Conflict of Interest." National Academies of Sciences, Engineering, and Medicine. 2022. Building Resilience into the Nation's Medical Product Supply Chains. Washington, DC: The National Academies Press. doi: 10.17226/26420.
×
Page 336
Building Resilience into the Nation's Medical Product Supply Chains Get This Book
×
 Building Resilience into the Nation's Medical Product Supply Chains
Buy Paperback | $45.00 Buy Ebook | $36.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Over the past several decades, supply chain disruptions have repeatedly plagued the U.S. health care system, costing health care systems millions of dollars per year, threatening the clinical research enterprise, and most importantly, imperiling the health and lives of patients. The Committee on Security of America's Medical Supply Chain, convened by the National Academies of Sciences, Engineering, and Medicine, was charged with addressing this important issue by examining the root causes of medical product shortages and identifying ways to enhance their resilience - both in so-called normal times and during public health emergencies.

Building Resilience into the Nation's Medical Product Supply Chains outlines the committee's seven recommendations and presents a framework of protection comprising awareness, mitigation, preparedness, and response measures.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!